S-Nitroso Human Serum Albumin Improves Oxygen Metabolism during Reperfusion after Severe Myocardial Ischemia
- 1 September 2004
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 72 (2) , 106-112
- https://doi.org/10.1159/000079139
Abstract
Nitric oxide (NO) supplementation may modify myocardial oxygen consumption and vascular function after ischemia. We investigated the effects of the NO donor, S-nitroso human serum albumin (S-NO-HSA), on cardiac oxygen metabolism during controlled reperfusion on normothermic cardiopulmonary bypass after severe myocardial ischemia. Pigs randomly received either S-NO-HSA or human serum albumin prior to and throughout global myocardial ischemia. Myocardial oxygen utilization is impaired at the onset of reperfusion, which is not amenable to S-NO-HSA. However, NO supplementation during ongoing supply dependency of oxygen consumption eventually leads to greater myocardial oxygen delivery and consumption. In conjunction with a better washout of lactate, this indicates an improved capillary perfusion in the S-NO-HSA group during reperfusion, which results in a better contractile function post bypass.Keywords
This publication has 5 references indexed in Scilit:
- S -Nitroso Human Serum Albumin Treatment Reduces Ischemia/Reperfusion Injury in Skeletal Muscle via Nitric Oxide ReleaseCirculation, 2002
- FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservationThe Journal of Heart and Lung Transplantation, 2000
- Exogenous Nitric Oxide Can Trigger a Preconditioned State Through a Free Radical Mechanism, But Endogenous Nitric Oxide Is Not a Trigger of Classical Ischemic PreconditioningJournal of Molecular and Cellular Cardiology, 2000
- ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injuryCardiovascular Research, 1997
- Nitric Oxide Mitigates Leukocyte Adhesion and Vascular Leak After Myocardial IschemiaJournal of Molecular and Cellular Cardiology, 1996